tiprankstipranks
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market
Holding REVB?
Track your performance easily

Revelation Biosciences (REVB) Financial Statements

105 Followers

Revelation Biosciences Financial Overview

Revelation Biosciences's market cap is currently ―. The company's EPS TTM is $-16.754; its P/E ratio is -0.05; Revelation Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.24M$ -8.39M$ -2.68M$ -2.78M$ -1.45M
EBITDA$ -2.23M$ -8.38M$ -2.68M$ -2.77M$ -1.44M
Net Income Common Stockholders$ -2.24M$ -8.39M$ -2.70M$ -2.63M$ -1.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.54M$ 12.07M$ 14.55M$ 13.99M$ 15.71M
Total Assets$ 6.74M$ 12.27M$ 14.70M$ 14.22M$ 16.04M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -6.54M$ -12.07M$ -14.55M$ -13.99M$ -15.71M
Total Liabilities$ 4.07M$ 11.13M$ 5.23M$ 5.40M$ 4.62M
Stockholders Equity$ 2.67M$ 1.14M$ 9.47M$ 8.82M$ 11.41M
Cash Flow-
Free Cash Flow$ -9.27M$ -2.48M$ -2.86M$ -1.72M$ -1.99M
Operating Cash Flow$ -9.26M$ -2.48M$ -2.84M$ -1.72M$ -1.99M
Investing Cash Flow$ -17.69K-$ -19.17K--
Financing Cash Flow$ 3.74M-$ 5.42M-$ 15.00
Currency in USD

Revelation Biosciences Earnings and Revenue History

Revelation Biosciences Debt to Assets

Revelation Biosciences Cash Flow

Revelation Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis